Argenica Therapeutics Director Acquires Options

Argenica Therapeutics Ltd (AU:AGN) has released an update.

Argenica Therapeutics Ltd has issued a new director’s interest notice, revealing that Director Dianne Angus has acquired 500,000 unlisted options following a shareholder meeting on August 14, 2024. These options have an exercise price of $0.93, with an expiry date of May 31, 2027, and were valued at $137,727 using the Black-Scholes option pricing model. This significant change in director’s interest could be indicative of internal confidence in the company’s future.

For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.